<DOC>
	<DOC>NCT02106832</DOC>
	<brief_summary>The purpose of this study is to evaluate if the time to first pulmonary exacerbation of bronchiectasis or its frequency can be prolonged by inhalation of ciprofloxacin for 28 days every other 28 days or for 14 days every other 14 days over 48 weeks.</brief_summary>
	<brief_title>Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Patients with a proven and documented diagnosis of non CF idiopathic or post infectious bronchiectasis Stable pulmonary status and stable regimen of standard treatment at least for the past 4 weeks Forced expiratory volume in 1 second (FEV1) &lt;30% or &gt;90% predicted Active allergic bronchopulmonary aspergillosis Active and actively treated non tuberculosis mycobacterial (NTM) infection or tuberculosis Primary diagnosis of Chronic obstructive pulmonary disease (COPD)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Ciprofloxacin</keyword>
	<keyword>Dry Powder for Inhalation</keyword>
	<keyword>Exacerbation</keyword>
	<keyword>Bronchiectasis</keyword>
</DOC>